EPC006	Causes of death for persons with HIV in an integrated healthcare system in Northern California, 2013-2017	E-poster	Natural history, morbidity patterns and survival
EPB068	A 2-year longitudinal examination of dosage of speed of processing training on Useful Field of View performance in adults 40+ with HIV-associated neurocognitive disorder: findings from the ThinkFast Study	E-poster	Neurologic disorders (e.g. CNS malignancies)
PESUB14	Low frequency of activated T cells in people living with HIV, aviremic under treatment, and presenting neurocognitive disorders	Poster exhibition	Neurologic disorders (e.g. CNS malignancies)
EPA082	Machine learning prediction and phyloanatomic modeling of viral neuroadaptive signatures in the macaque model of human immunodeficiency virus-mediated neuropathology	E-poster	Neuropathogenesis
PESUA24	Chronic CNS inflammation in ART-suppressed SIV-infected rhesus macaques is associated with immune activation and viral persistence in the gut	Poster exhibition	Neuropathogenesis
EPB010	'I feel drug resistance testing was giving us an informed decision': qualitative insights on HIV drug resistance testing among children and pregnant women living with HIV in western Kenya	E-poster	Novel approaches to assess viral load and ARV resistance/tropism
EPLBB07	A point-of-care triage test for HIV virological failure: filling the gaps in viral load coverage	E-poster	Novel approaches to assess viral load and ARV resistance/tropism
EPB008	DHIVAx: a novel HIV-1 antibody test unaffected by vaccine-induced seroreactivity	E-poster	Novel assays of immune responses
EPB009	Comparison of different methods for the detection of HLA 57:01 allele in people living with HIV (PLWHIV) Easter Uttar Pradesh, India	E-poster	Novel assays of immune responses
EPA037	MVA/Protein HIV-1 vaccine protects against heterologous SHIV infection by modulating IgG glycosylation and T helper response in macaques	E-poster	Novel vectors, adjuvants and strategies